IndraLab

Statements

USP9X activates MTTP. 1 / 1

| 1

reach

"The median time to progression (MTP) of all patients treated with CTX was six weeks and the MTP of patients treated with FAM ' was 16 weeks (P less than.007)."

3838343

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP9X activates MTTP. 1 / 1

INDRA sources:

Databases

Reading